324 related articles for article (PubMed ID: 25652347)
1. Improving outcomes for neurofibromatosis 1-associated brain tumors.
Brossier NM; Gutmann DH
Expert Rev Anticancer Ther; 2015 Apr; 15(4):415-23. PubMed ID: 25652347
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
Amato A; Imbimbo BP; Falsini B
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
[TBL] [Abstract][Full Text] [Related]
3. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
[TBL] [Abstract][Full Text] [Related]
4. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
Freret ME; Gutmann DH
J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
[TBL] [Abstract][Full Text] [Related]
5. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
6. Optic Pathway Gliomas in Neurofibromatosis Type 1.
Campen CJ; Gutmann DH
J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
[TBL] [Abstract][Full Text] [Related]
7. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.
Solga AC; Pong WW; Kim KY; Cimino PJ; Toonen JA; Walker J; Wylie T; Magrini V; Griffith M; Griffith OL; Ly A; Ellisman MH; Mardis ER; Gutmann DH
Neoplasia; 2015 Oct; 17(10):776-88. PubMed ID: 26585233
[TBL] [Abstract][Full Text] [Related]
8. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
[TBL] [Abstract][Full Text] [Related]
9. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
Sharif S; Ferner R; Birch JM; Gillespie JE; Gattamaneni HR; Baser ME; Evans DG
J Clin Oncol; 2006 Jun; 24(16):2570-5. PubMed ID: 16735710
[TBL] [Abstract][Full Text] [Related]
10. Brainstem gliomas in children and adults.
Laigle-Donadey F; Doz F; Delattre JY
Curr Opin Oncol; 2008 Nov; 20(6):662-7. PubMed ID: 18841048
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Chen Y; Yu J; Ge S; Jia R; Song X; Wang Y; Fan X
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):8. PubMed ID: 38837168
[TBL] [Abstract][Full Text] [Related]
14. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications.
Shamji MF; Benoit BG
Neurosurg Focus; 2007; 23(5):E3. PubMed ID: 18004965
[TBL] [Abstract][Full Text] [Related]
15. 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.
Anderson DM; Van de Plas R; Rose KL; Hill S; Schey KL; Solga AC; Gutmann DH; Caprioli RM
J Proteomics; 2016 Oct; 149():77-84. PubMed ID: 26883872
[TBL] [Abstract][Full Text] [Related]
16. Gliomas in patients with neurofibromatosis type 1.
Albers AC; Gutmann DH
Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
[TBL] [Abstract][Full Text] [Related]
17. Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.
Johnson KJ; Zoellner NL; Gutmann DH
Cancer Epidemiol; 2016 Jun; 42():53-9. PubMed ID: 27018750
[TBL] [Abstract][Full Text] [Related]
18. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
[TBL] [Abstract][Full Text] [Related]
19. Optic pathway gliomas in children with and without neurofibromatosis 1.
Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
